NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Sam Altman’s World project has launched in the U.S. It scans users’ irises in exchange for crypto, raising fresh concerns about privacy, biometric data and AI-linked identity systems.Read More